Key result
A 61-year-old female with anti-Hu-associated syndrome developed pseudoachalasia nearly 90 months after her first neurological manifestation, which was successfully treated with botulinum toxin.
Why the study?
Pseudoachalasia is a rare manifestation of anti-Hu-associated syndrome.
Case Report (n=1)
Anti-Hu-associated paraneoplastic pseudoachalasia may occur late in the clinical course, indicating that new-onset dysphagia in anti-Hu-positive individuals should be thoroughly investigated.
New dysphagia in anti-Hu-positive patients warrants evaluation for late paraneoplastic pseudoachalasia; extends awareness but remains hypothesis-generating from one case.
Background: Pseudoachalasia is a rare manifestation of anti‐Hu‐associated syndrome. We present the case of a 61‐year‐old female patient presenting primarily with progressive pain and sensory disturbance of all limbs. Neurological symptoms progressed after the primary treatment response and onconeural anti‐Hu‐antibodies were tested positive, which is often a surrogate to paraneoplastic syndrome. Subsequently, after repeated imaging, a lung carcinoid tumor was resected without detectable recurrence after surgery. Nearly 90 months after the first neurological manifestation, the patient developed dysphagia and the diagnosis of pseudoachalasia was established by esophageal manometry. Due to recurrence after pneumatic dilatation, endoscopic botulinum toxin injection provided good clinical results for the patient. Purpose: This case illustrates that anti‐Hu‐associated paraneoplastic pseudoachalasia may occur late in the clinical course, indicating that new‐onset dysphagia in anti‐Hu‐positive individuals should be thoroughly investigated by imaging, endoscopy, manometry, and histology.
No takes yet. Share an insight, caveat, or question.
Jürgensen et al. (2025) conducted a case report in Anti-Hu-associated syndrome (n=1). Anti-Hu-associated syndrome was evaluated on Development of pseudoachalasia. A 61-year-old female with anti-Hu-associated syndrome developed pseudoachalasia nearly 90 months after her first neurological manifestation, which was successfully treated with botulinum toxin.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: